RH
Reza Halse
Partner at Droia Ventures
West Newton, Massachusetts
Overview
Reza Halse is a Partner at Droia Ventures, with a background in cell biology, genomics, and biotechnology. He has held significant leadership roles at Merck, RA Capital Management, and MSD, and has been involved in the success of various companies through his board responsibilities and investments in therapeutics and biotech sectors.
Highlights of Reza Halse's career include serving as the Head of Pacific BD&L Hub at Merck and being a Partner at RA Capital Management, showcasing his expertise in venture capital, drug discovery, and commercialization within the pharmaceutical industry. Additionally, his current role as a Partner at Droia Ventures allows him to leverage his extensive experience in technology transfer and clinical development to support companies in their growth and development.
Work Experience
Partner
2023 - 2025
Partner, RA Ventures
2021 - 2023
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Head, Pacific BD&L Hub (Vice President)
2019 - 2021
President, MRL Ventures Fund
2017 - 2021
Previous Board responsibilities
2012 - 2021
Associate Vice President and Head of MSD European Innovation Hub; Partner, MRL Venture Fund
2015 - 2016
Rez leads the MSD London Innovation Hub with responsibility for business development and licensing activities in Europe; he is also a Partner in MRL Ventures. Recognizing the importance of life-science innovation in Europe, MSD has established the London Innovation Hub as a focal point for developing academic and commercial partnerships. The Hub offers a range of partnering constructs to match the interests of European innovators: collaborations, licensing and independent venture investments, through MRL Ventures.
Chair, Core Evaluation Team, Genomic Applications Partnership Program
2013 - 2016
Partner, Innovation Fund
2012 - 2015
CEO
2014 - 2015
Director
2008 - 2011
Associate Director
2004 - 2008
Education
PhD
1993 - 2001